###### Strengths and limitations of this study

-   This study provided important insights into the accuracy of point-of-care testing (POCT) capillary and venous blood lactate in undifferentiated Hong Kong adult patients with urgent conditions.

-   We used two handheld devices to determine the accuracy of the POCT capillary and venous lactate.

-   Bland-Altman agreement analyses of the mean difference in lactate between the reference standard and the measurements using handheld analysers were performed.

-   However, the overall reliability of the procedure may be affected by the design of the analysers and endogenous patient factors including oxygen levels, skin temperature and altered haematocrit levels.

Introduction {#s1}
============

Elevated lactate levels are a common finding in acutely unwell patients. Blood lactate level is a good predictor of patient outcome and high lactate levels are associated with high morbidity and mortality.[@R1] Lactate may be detected and measured in all blood samples: arterial, venous and capillary. Good correlation of lactate concentrations between arterial and venous blood samples have been noted.[@R3] Due to the possible risk and the additional time required to obtain an arterial sample, it has been suggested that venous blood gas (VBG) analysis can replace arterial blood gas analysis in the emergency department (ED).[@R5] In particular, venous lactate has demonstrated to be reliable in the management of trauma and sepsis in the ED.[@R6]

Currently, blood lactate can be measured formally in the laboratory, using blood gas analysers or with handheld devices. Strong correlations have been shown between blood lactate levels in samples analysed in the central laboratory, by blood gas analysers[@R8] and handheld devices.[@R10] The turnover time of using handheld devices is significantly shorter than the samples analysed in the central laboratory.[@R10] Comparing to arterial and venous blood sample, obtaining capillary blood samples is quick, less painful[@R12] and the technique is already well known to ED healthcare workers. Along with its small blood volume requirement for analysis and rapid availability of results, handheld analysers could potentially allow earlier identification of patients with a higher risk of mortality. Handheld analysers could reduce the time needed for clinical decisions and potentially improve the quality of care, with the potential to extend their use to the triage area or the prehospital setting.

However, there are conflicting reports on the accuracy of this rapid capillary lactate measurement using handheld devices. Previous studies have inconsistent results on agreement between capillary blood lactate and venous blood lactate. Capillary blood lactate has been shown to have good agreement with lactate levels in venous samples in newborns.[@R13] In contrast, poor agreement between capillary lactate and venous blood lactate were observed in adult ED patients.[@R14] The small sample size ranging from 24 to 120 of previous studies limited the generalisation of these studies.

Crowding in ED prolongs patient waiting times, especially from triage to physician assessment. Point-of-care testing (POCT) such as rapid lactate measurement could aid early recognition of patients at high risk of mortality and morbidity.[@R6] The aim of this study was to study the agreement of handheld lactate analysers for the measurement of capillary lactate as compared with a reference standard, namely venous blood lactate level assessed using a blood gas analyser.

We hypothesised that there would be good agreement, as defined by Bland-Altman analysis,[@R18] between capillary blood lactate levels analysed with handheld analysers compared with venous blood lactate levels analysed with a blood gas analyser. There is no standard definition of what is considered good agreement. We considered that if the point estimate of the limit of agreement (LOA)[@R18] was within ±0.4 mmol/L (equivalent to ± 20% of the upper limit of normal lactate value of 2 mmol/L) from the point estimate of the bias would be clinically acceptable. Similarly, good agreement was defined as having LOA within ± 0.2 mmol/L (equivalent to ± 10% of upper limit of the normal lactate value of 2 mmol/L) from the point estimate of the bias.

Material and methods {#s2}
====================

Study design and patients {#s2a}
-------------------------

This was a prospective observational study of patients presenting to the ED of Prince of Wales Hospital, a tertiary university teaching hospital in Hong Kong with an annual census of 140 000 attendances.

Inclusion criteria were patients aged ≥18 years presenting to the ED who were triaged as category 3 (urgent).[@R19] Exclusion criteria included pregnant patients or those aged ≤17 years.

Sample collection and lactate analysis {#s2b}
--------------------------------------

Venous and capillary blood samples were collected for lactate analysis. Venous blood samples (approximate 1 mL) were collected by venepuncture while capillary blood samples were collected by finger-prick with a disposable lancet. Venous lactate levels measured by blood gas analyser (Siemens Automatic QC RAPID Systems RAPID Point\@500, Siemens Healthcare Diagnostics, New York, USA) served as the reference standard. Capillary lactate levels were immediately analysed by two handheld lactate analysers: Nova StatStrip Xpress Lactate Meter (Nova Biomedical, Waltham, Massachusetts, USA) and Lactate Scout+ (EKF Diagnostics, Leipzig, Germany). Venous lactate levels were also measured on the two handheld lactate analysers. All lactate measurements were performed within 15 min after obtaining the venous sample.

Data collection {#s2c}
---------------

Basic patient characteristics including age and sex, vital parameters recorded at triage (blood pressure, heart rate, respiratory rate and temperature) were also documented.

Outcomes {#s2d}
--------

The primary outcome measure was the agreement of the capillary blood lactate level measured by handheld lactate analyser when compared with the reference standard technique, namely venous blood sample obtained by venepuncture and analysed using the blood gas analyser.

The secondary outcome measure was the difference in values of venous lactate using blood gas analyser and handheld lactate analysers.

Statistical analysis {#s2e}
--------------------

Agreement of handheld lactate analysers with blood gas analyser was analysed by using Bland-Altman agreement analysis.[@R18] 95% (mean ±1.96 SD) LOA were generated for each Bland-Altman analysis. All analyses were carried out using MedCalc V.15.8 for Windows (Ostend, Belgium).

Sample size {#s2f}
-----------

The sample size suggested based on the Bland-Altman method was 200.[@R18] We allowed an extra 20% for unforeseen circumstances, and therefore the final sample size for this study was 240 (200×120% =240).

Definitions {#s3}
===========

VL-Ref, the venous lactate level measured by blood gas analyser, served as the reference standard. VL-Nova and VL-Scout+ are venous lactate levels measured by handheld lactate analysers Nova StatStrip Xpress Lactate Meter and Lactate Scout+ Analyzer, respectively. CL-Nova and CL-Scout+ are capillary lactate levels measured by handheld lactate analysers Nova StatStrip Xpress Lactate Meter and Lactate Scout+ Analyzer, respectively.

Patient and public involvement {#s4}
==============================

The development of research question and outcome measures were not informed by patient's priorities, experience and preferences. Patients were not involved in the design of studies in Hong Kong at the time this study was proposed. They were not involved in the recruitment or the conduct of the study. Results have been made available for patients on request.

Results {#s5}
=======

Two hundred and forty patients (mean age 69.9 years; 54.2% males) were recruited ([table 1](#T1){ref-type="table"}). Of the 240 patients, 63.8% showed a venous lactate level (VL-Ref) \<2 mmol/L and 36.2%≥2 mmol/L. VL-Ref ranged from 0.70 to 5.38 mmol/L, mean 1.96 mmol/L (SD 0.88 mmol/L).

###### 

Basic characteristics of 240 patients

  Characteristics                    Value
  ---------------------------------- ------------------------
  Age                                69.9±16.1 (20--99)
  Sex (male)                         130 (54.2%)
  Temperature (°C)                   36.9±0.91 (34.9--40.4)
  Systolic blood pressure (mm Hg)    141.7±23.7 (93--217)
  Diastolic blood pressure (mm Hg)   74.8±15.5 (31--143)
  Heart rate (/min)                  83.5±18.9 (45--132)
  Respiratory rate (/min)            17.1±4.1 (12--32)
  Lactate measurement                
  Venous (Reference)                 2.0±0.9 (0.7--5.4)
  Venous (Nova)                      1.1±0.6 (0.3--4.7)
  Venous (Scout+)                    1.7±0.8 (0.5--5.5)
  Capillary (Nova)                   1.5±0.8 (0.4--6.0)
  Capillary (Scout+)                 2.2±1.2 (0.6--9.2)

All continuous data are expressed as mean±SD and range.

Out of the samples from the 240 subjects, two CL-Scout +samples and two CL-Nova samples were lost due to analyser errors and subsequent refusals from patients to have blood samples redrawn. Samples of VL-Ref, VL-Scout+ and VL-Nova for data analysis were 240 collectively.

Mean differences and (Bland-Altman) LOA, together with 95% CIs, for differences between capillary and venous readings from the two handheld devices and the reference, blood gas, values are given in [table 2](#T2){ref-type="table"}, and separately for reference values \<2 mmol/L and ≥2 mmol/L in [table 3](#T3){ref-type="table"}. Bland-Altman plots are shown in [figure 1](#F1){ref-type="fig"}.

###### 

Agreement between capillary blood lactate and venous blood lactate

  Group               *n*   Mean difference (95% CI) Lower   Limits of agreement (95% CI)   
  ------------------- ----- -------------------------------- ------------------------------ ---------------------
  VL-Ref (all)                                                                              
   VL-Ref/CL-Scout+   238   −0.22 (−0.35 to −0.09)           −2.17 (−2.39 to −1.95)         1.73 (1.51 to 1.95)
   VL-Ref/CL-Nova     238   0.46 (0.36 to 0.56)              −1.08 (−1.25 to −0.91)         2.00 (1.83 to 2.18)
   VL-Ref/VL-Scout+   240   0.22 (0.17 to 0.26)              −0.46 (−0.53 to −0.39)         0.90 (0.82 to 0.98)
   VL-Ref/VL-Nova     240   0.83 (0.77 to 0.88)              −0.01 (−0.10 to 0.084)         1.66 (1.57 to 1.76)

The point estimate of the level of agreement (LOA) being within ±0.4 mmol/L from the point of the bias considered as clinically acceptable; and the point estimate of the LOA within ±0.2 mmol/L from the point of the bias considered as good agreement.

###### 

Agreement between capillary blood lactate and venous blood lactate of subgroup VL-Ref \<2 mmol/L and VL-Ref ≥2 mmol/L

  Group               n     Mean difference (95% CI) Lower   Limits of agreement (95% CI)   
  ------------------- ----- -------------------------------- ------------------------------ ---------------------
  VL-Ref \<2 mmol/L                                                                         
   VL-Ref/CL-Scout+   151   −0.32 (−0.47 to −0.17)           −2.13 (−2.39 to −1.88)         1.49 (1.23 to 1.74)
   VL-Ref/CL-Nova     149   0.20 (0.10 to 0.31)              −1.06 (−1.24 to −0.88)         1.46 (1.29 to 1.64)
   VL-Ref/VL-Scout+   151   0.16 (0.12 to 0.20)              −0.36 (−0.43 to −0.28)         0.67 (0.60 to 0.75)
   VL-Ref/VL-Nova     151   0.62 (0.59 to 0.65)              0.23 (0.18 to 0.29)            1.00 (0.95 to 1.06)
  VL-Ref≥2 mmol/L                                                                           
   VL-Ref/CL-Scout+   87    −0.04 (−0.28 to 0.19)            −2.18 (−2.58 to −1.78)         2.09 (1.70 to 2.49)
   VL-Ref/CL-Nova     89    0.89 (0.72 to 1.07)              −0.71 (−1.01 to −0.42)         2.50 (2.20 to 2.79)
   VL-Ref/VL-Scout+   89    0.32 (0.22 to 0.41)              −0.55 (−0.71 to −0.39)         1.18 (1.02 to 1.34)
   VL-Ref/VL-Nova     89    1.18 (1.08 to 1.28)              0.25 (0.077 to 0.42)           2.11 (1.94 to 2.29)

The point estimate of the level of agreement (LOA) being within ±0.4 mmol/L from the point of the bias considered as clinically acceptable; and the point estimate of the LOA within ±0.2 mmol/L from the point of the bias considered as good agreement.

![Bland-Altman plots showing the agreement between venous blood lactate using blood gas analyser (VL-Ref) and (A) capillary blood lactate level obtained by handheld analyser Scout+ (CL-Scout+) and Nova (CL-Nova), (B) venous blood lactate level obtained by handheld analyser Scout+ (VL-Scout+) and Nova (VL-Nova). Solid line represents bias; dashed lines represent upper and lower 95% limits of agreement.](bmjopen-2018-026109f01){#F1}

Discussion {#s6}
==========

This study demonstrates that there is low systematic bias but a wide LOA between the capillary lactate measured with the Scout +analyser (CL-Scout+) and the 'reference standard' venous lactate measured by the blood gas analyser (VL-Ref). Furthermore, there is high systematic bias and a wide LOA between CL-Nova and VL-Ref. These findings suggest that capillary lactate measurement by handheld lactate analysers is not interchangeable with the current reference methods for lactate for diagnostic purposes.

In common with our study, a small mean difference but wide LOAs were observed between capillary lactate and reference methods in other ED patients[@R14] and trauma patients.[@R14] The sample size of these three studies ranged from 24 to 120 patients. Our current study with a larger sample size (n=240) confirms the poor agreement between capillary lactate and venous lactate. These findings indicate that there is poor precision between the two methods. Such poor precision suggests that handheld capillary lactate testing cannot replace the current reference methods for lactate estimation in the ED. In contrast, good agreement between capillary and arterial lactate was observed in newborns in the neonatal ICU.[@R13] Further studies are required to compare the use of handheld lactate analysers between children and adult patients.

The present findings showed that different results were obtained using different handheld lactate analysers. The results suggest that the Scout +overestimates lactate levels and the Nova underestimates lactate levels. Overestimation of lactate levels may lead to unnecessary clinical intervention, while underestimation of lactate levels may delay intervention.[@R22]

Among venous lactate level measurements, both the Scout +and Nova lactate handheld analyser failed to meet the definitions for good/clinically acceptable agreements compared with the reference blood gas analyser (VL-Ref). This is in contrast with the good agreement found between venous blood lactate using a handheld lactate analyser (i-STAT) and a central laboratory lactate analysis[@R10] in previous studies.

Although failing to meet the acceptable agreement criteria, better agreement was noted in the subgroup of patients with reference lactate levels \<2 mmol/L between VL-Scout+ and VL-Ref. This suggests that within normal lactate levels, the Scout+ handheld lactate analyser may have the potential to screen patients who should or should not have further formal lactate measurements using VBG analysis as a POCT or in the central laboratory. Screening ED venous lactate levels by handheld analyser could provide information to shorten the time to identification of patients at risk, to allow rapid decision making for further treatment. However, the poor agreement between VL-Nova and VL-Ref suggests that the Nova lactate handheld analyser is not suitable for clinical use in the ED.

Our results do not currently support the use of capillary lactate measurement for diagnostic purposes. However, portable handheld analysers have the great advantage of reduced turn-around times, requiring only a small amount of blood, affordable cost, and being easily accessible[@R23] allowing the use of this procedure in hospital, and in the prehospital setting including nursing homes. Further improvements in agreement are required to allow stronger recommendations for the routine use of handheld lactate analysers.

Limitations of the study {#s6a}
------------------------

Capillary blood lactate testing with handheld analysers has great potential advantages. However, the overall reliability of the procedure may be affected by the design of the analysers, endogenous patient factors and operational errors. Endogenous patient factors such as oxygen levels, skin temperature and altered haematocrit may influence the results of handheld lactate analysers.[@R25] Furthermore, operational errors may contribute towards the imprecision of the capillary lactate testing. Capillary lactate testing only requires a small amount of blood for analysis and this may allow easy contamination of the sample to occur, by sweat,[@R25] disinfectant and alcohol swabs, for example.

Conclusion {#s7}
==========

The current study shows poor agreement between capillary lactate and the reference method. Our results do not support the clinical use of capillary lactate POCT. However, venous lactate measured by Scout+ handheld analyser may have potential for screening patients who may need further testing using more definitive methods.
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